The Aldeyra Therapeutics Inc (ALDX) Releases Quarterly Earnings Results, Misses Estimates By $0.04 EPS

The Aldeyra Therapeutics Inc (ALDX) Releases Quarterly  Earnings Results, Misses Estimates By $0.04 EPS

Aldeyra Therapeutics (ALDX) opened at 5.45 on Monday. Aldeyra Therapeutics has a one year low of $3.80 and a one year high of $8.19. The company’s 50-day moving average is $4.45 and its 200-day moving average is $5.00. The firm’s market cap is $34.04 million.

Aldeyra Therapeutics Inc (NASDAQ:ALDX) announced its earnings results on Monday. The biotechnology company reported ($0.37) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.33) by $0.04, Bloomberg Earnings reports.

Hedge funds and other institutional investors have recently modified their holdings of the company. Renaissance Technologies LLC bought a new position in shares of Aldeyra Therapeutics during the first quarter valued at approximately $132,000. Hikari Power Ltd bought a new position in shares of Aldeyra Therapeutics during the first quarter valued at approximately $188,000. Geode Capital Management LLC raised its position in shares of Aldeyra Therapeutics by 3.6% in the first quarter. Geode Capital Management LLC now owns 54,888 shares of the biotechnology company’s stock valued at $274,000 after buying an additional 1,912 shares during the period. Sabby Management LLC bought a new position in shares of Aldeyra Therapeutics during the first quarter valued at approximately $898,000. Finally, Knoll Capital Management LP bought a new position in shares of Aldeyra Therapeutics during the third quarter valued at approximately $1,038,000. Institutional investors and hedge funds own 48.60% of the company’s stock.

About Aldeyra Therapeutics Aldeyra Therapeutics, Inc, formerly Aldexa Therapeutics, Inc, is a biotechnology company. The Company’s principal activities include raising capital and research and development activities. The Company’s segment is the identification and development of a treatment for diseases related to high levels of aldehydes.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:ALDX”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for Aldeyra Therapeutics Inc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aldeyra Therapeutics Inc and related companies with our FREE daily email newsletter.

Related posts

Leave a Comment